Christopher Thomas Giordano, CEO of Tenax Therapeutics TENX, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $20K. The latest trade was on 01/09.

CG

CG

Christopher Thomas Giordano

CEO

Company

Tenax Therapeutics TENX

First filing

24/05/21

Trades

7 trades

Buys / sales

3 / 0

12-month net buying

$20K

Last trade

01/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Tenax TherapeuticsTENX	Open-market buy	25/11/18–25/11/20	25/11/20	2,605 sh3 trades	$7.68avg.	$19,993.47	No record